SHARED DECISION-MAKING TO IMPROVE UPTAKE OF AND ADHERENCE WITH ORAL ANTICOAGULATION THERAPY FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
Summary
This study aims to help improve the process of starting patients with atrial fibrillation on stroke prevention therapy. To achieve this, patients are placed on blood thinners to reduce their chance of developing stroke. There are five choices of medication to choose from. These drugs have different side effects and benefits. Some of them require monthly testing to ensure optimal functioning and dosing.
We have designed a web-based tool to help communicate these information and options in a manner they can relate to using pictures and words. However, we need to test their use in the clinical setting to better understand how it can help us increase patient knowledge and understanding of the disease while stating the importance of use of their blood thinners to minimize their chance of developing stroke.
Eligibility
Eligible gender: Male, Female, Transgender, Other
Eligible ages: 18 to 120
Inclusion criteria:
Newly diagnosed adults (older than 18 years) with atrial fibrillation who are yet to be commenced on blood thinners or recently started on the medication within 6 months.
Exclusion criteria:
Adults with a previous diagnosis of atrial fibrillation or patients previously placed on blood thinners for other reasons
Participate
Additional information
Contact information
Through hospital admission or physician referral only
Principal investigator:
Stephen Wilton
Clinical trial:
Yes
REB-ID:
REB22-1737